Haematology
MK-1026
A Phase 2/3 Relapsed and/or Refractory Multiple Myeloma study
Trial overview
Description
A Phase 2/3, Randomized, Open-Label Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
Study details
For detailed information on this trial, please click here.
Trial status
Recruiting
Location
Priniciple Investigator
